Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | KUR-502 |
Trade Name | |
Synonyms | KUR 502|KUR502|CMD 502 |
Drug Descriptions |
Limited information is available on KUR-502, a putative cell therapy comprising allogeneic natural killer T-lymohocytes expressing a chimeric antigen receptor (CAR) targeting CD19 (Nov 2023). |
DrugClasses | CD19 Immune Cell Therapy 62 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
KUR-502 | KUR-502 | 0 | 1 |